These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 20015470)

  • 1. Blending of agglomerates into powders 1: Quantification of abrasion rate.
    Willemsz TA; Oostra W; Hooijmaijers R; de Vegt O; Morad N; Vromans H; Frijlink HW; Van der Voort Maarschalk K
    Int J Pharm; 2010 Mar; 387(1-2):87-92. PubMed ID: 20015470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic energy density and agglomerate abrasion rate during blending of agglomerates into powders.
    Willemsz TA; Hooijmaijers R; Rubingh CM; Tran TN; Frijlink HW; Vromans H; van der Voort Maarschalk K
    Eur J Pharm Sci; 2012 Jan; 45(1-2):211-5. PubMed ID: 22127372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The consequences of granulate heterogeneity towards breakage and attrition upon fluid-bed drying.
    Nieuwmeyer F; van der Voort Maarschalk K; Vromans H
    Eur J Pharm Biopharm; 2008 Sep; 70(1):402-8. PubMed ID: 18440211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the effects of high shear blending on lactose and drug using fluidised bed elutriation.
    Willetts JP; Robbins PT; Roche TC; Bowley M; Bridson RH
    Int J Pharm; 2012 Sep; 434(1-2):272-9. PubMed ID: 22683647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entrainment of lactose inhalation powders: a study using laser diffraction.
    Watling CP; Elliott JA; Cameron RE
    Eur J Pharm Sci; 2010 Jul; 40(4):352-8. PubMed ID: 20417708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humidity-induced changes of the aerodynamic properties of dry powder aerosol formulations containing different carriers.
    Zeng XM; MacRitchie HB; Marriott C; Martin GP
    Int J Pharm; 2007 Mar; 333(1-2):45-55. PubMed ID: 17064863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aerosolization properties, surface composition and physical state of spray-dried protein powders.
    Bosquillon C; Rouxhet PG; Ahimou F; Simon D; Culot C; Préat V; Vanbever R
    J Control Release; 2004 Oct; 99(3):357-67. PubMed ID: 15451594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Precipitated silica as flow regulator.
    Müller AK; Ruppel J; Drexel CP; Zimmermann I
    Eur J Pharm Sci; 2008 Aug; 34(4-5):303-8. PubMed ID: 18595668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microscale granulation in a fluid bed powder processor using electrostatic atomisation.
    Kivikero N; Murtomaa M; Ingelbeen B; Antikainen O; Räsänen E; Mannermaa JP; Juppo AM
    Eur J Pharm Biopharm; 2009 Jan; 71(1):130-7. PubMed ID: 18703138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of amorphous content on compaction behaviour of anhydrous alpha-lactose.
    Ziffels S; Steckel H
    Int J Pharm; 2010 Mar; 387(1-2):71-8. PubMed ID: 20005927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Raman spectroscopy as a process analytical technology (PAT) tool for the in-line monitoring and understanding of a powder blending process.
    De Beer TR; Bodson C; Dejaegher B; Walczak B; Vercruysse P; Burggraeve A; Lemos A; Delattre L; Heyden YV; Remon JP; Vervaet C; Baeyens WR
    J Pharm Biomed Anal; 2008 Nov; 48(3):772-9. PubMed ID: 18799281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thin-coating as an alternative approach to improve flow properties of ibuprofen powder.
    Genina N; Räikkönen H; Ehlers H; Heinämäki J; Veski P; Yliruusi J
    Int J Pharm; 2010 Mar; 387(1-2):65-70. PubMed ID: 20005929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Shear-induced APAP de-agglomeration.
    Llusa M; Levin M; Snee RD; Muzzio FJ
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1487-95. PubMed ID: 19929208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of high shear blending on alpha-lactose monohydrate.
    Bridson RH; Robbins PT; Chen Y; Westerman D; Gillham CR; Roche TC; Seville JP
    Int J Pharm; 2007 Jul; 339(1-2):84-90. PubMed ID: 17398047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of milling and sieving on functionality of dry powder inhalation products.
    Steckel H; Markefka P; teWierik H; Kammelar R
    Int J Pharm; 2006 Feb; 309(1-2):51-9. PubMed ID: 16377105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a micro dosing system for fine powder using a vibrating capillary. Part 1: the investigation of factors influencing on the dosing performance.
    Chen X; Seyfang K; Steckel H
    Int J Pharm; 2012 Aug; 433(1-2):34-41. PubMed ID: 22595639
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Centrifugal air-assisted melt agglomeration for fast-release "granulet" design.
    Wong TW; Musa N
    Int J Pharm; 2012 Jul; 430(1-2):184-96. PubMed ID: 22531845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving powder flow properties of a cohesive lactose monohydrate powder by intensive mechanical dry coating.
    Zhou Q; Armstrong B; Larson I; Stewart PJ; Morton DA
    J Pharm Sci; 2010 Feb; 99(2):969-81. PubMed ID: 19795479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preparation method on compactability of paracetamol granules and agglomerates.
    Fichtner F; Rasmuson AC; Alander EM; Alderborn G
    Int J Pharm; 2007 May; 336(1):148-58. PubMed ID: 17196775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low powder mass filling of dry powder inhalation formulations.
    Eskandar F; Lejeune M; Edge S
    Drug Dev Ind Pharm; 2011 Jan; 37(1):24-32. PubMed ID: 20738180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.